Funding Opportunity PAR-22-165 from the NIH Guide for Grants and Contracts. Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) announces its interest in supporting meritorious research projects in three distinct domains related to cancer communication: 1) the utility and application of new cancer communication surveillance approaches; 2) the development and testing of rapid cancer communication pilot interventions using innovative methods and designs; and 3) the development and testing of multilevel cancer communication models emphasizing bidirectional influence between levels. For such projects, applicants should apply communication science approaches to the investigation of behavioral targets and health outcomes related to cancer prevention and control. Applications should utilize one or more innovative communication research methodologies.

Funding Opportunity PAR-22-164 from the NIH Guide for Grants and Contracts. Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) announces its interest in supporting meritorious research projects in three distinct domains related to cancer communication: 1) the utility and application of new cancer communication surveillance approaches; 2) the development and testing of rapid cancer communication interventions using innovative methods and designs; and 3) the development and testing of multilevel cancer communication models emphasizing bidirectional influence between levels. For such projects, applicants should apply communication science approaches to the investigation of behavioral targets and health outcomes related to cancer prevention and control. Applications should utilize one or more innovative communication research methodologies.

Notice NOT-DA-22-069 from the NIH Guide for Grants and Contracts

Notice NOT-RM-22-015 from the NIH Guide for Grants and Contracts

Experience with sequencing and single-cell analysis is preferred; computational/bioinformatic experience is desired, but not required.
From Medical College of Wisconsin - Fri, 10 Jun 2022 15:09:01 GMT - View all Milwaukee, WI jobs

Funding Opportunity RFA-DA-23-020 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to inspire and support research to advance the drug and device development tools for ultimate submission to DDT or MDDT tool qualification program within either FDAs CDER or CDRH. The funding will be used to further the development of tools that, once qualified, will be available to fill unmet needs in SUD biomedical product development. This FOA ultimately aims to bring innovative treatments to SUD patients faster.

Funding Opportunity RFA-DA-23-019 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to inspire and support research to advance the drug and device development tools for ultimate submission to DDT or MDDT tool qualification program within either FDAs CDER or CDRH. The funding will be used to further the development of tools that, once qualified, will be available to fill unmet needs in SUD biomedical product development. This FOA ultimately aims to bring innovative treatments to SUD patients faster.

Funding Opportunity RFA-DK-22-001 from the NIH Guide for Grants and Contracts. This U2C funding opportunity announcement (FOA) is a National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) initiative to establish a novel national Stakeholder Engagement Innovation Center for advancing equity in type 2 diabetes research (SEIC-T2D). A primary goal of the SEIC-T2D is to accelerate equitable engagement of diverse stakeholders in T2D research, particularly those from diverse communities that experience diabetes-related health disparities, and systems that impact their health. The SEIC-T2D will provide highly specialized research resources to support investigators by fully embedding communities, patients, and other stakeholders into the full spectrum of research activities through expert consultations and education in principles and methods of community-engaged research. The SEIC-T2D will also establish a network consisting of diverse, multidisciplinary research investigators with expertise in T2D and community-engaged methods, community experts with lived experiences, and representatives of various health and other organizations deemed essential for addressing disparities and advancing health equity in T2D prevention and treatment.

Notice NOT-OD-22-155 from the NIH Guide for Grants and Contracts

Notice NOT-EB-22-008 from the NIH Guide for Grants and Contracts

From £37,000 with benefits, subject to skills and experience: The Francis Crick Institute: The Francis Crick Institute seeks a talented and highly motivated bioinformatics analyst to work across the Proteomic and Metabolomic (STPs). London (Greater) (GB)

Funding Opportunity PAR-22-181 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) solicits R01 grant applications that propose independent research projects that are within the scientific mission areas of the ?participating NIH Institutes or Centers. This program is intended to support New Investigators and At-Risk Investigators from diverse backgrounds, including those from groups underrepresented in the health-related sciences.Investigators from diverse backgrounds, including those from underrepresented groups (e.g., see NOT-OD-20-031, Notice of NIHs Interest in Diversity), are eligible to apply. Investigators from categories A and B are particularly encouraged to work with their institutions to apply

Funding Opportunity RFA-AG-23-023 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites Exploratory/Developmental Grants (R21) applications for the development of methods and measures for capturing expanded definitions of family and related concepts relevant to informal caregiving for people living with Alzheimers disease (AD) and Alzheimers disease related dementias (ADRD), and for the testing of these measures in populations underrepresented in AD/ADRD research. This FOA and RFA-AG-23-022 are companion announcements. RFA-AG-23-022 invites Research Project Grant (R01) applications. Applications with preliminary data are encouraged to apply to RFA-AG-23-022, while high risk/high payoff projects that lack preliminary data may be more appropriate for this FOA.

Funding Opportunity RFA-AG-23-022 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites Research Project Grant (R01) applications for the development of methods and measures for capturing expanded definitions of family and related concepts relevant to informal caregiving for people living with Alzheimers disease and Alzheimers disease related dementias (AD/ADRD), and for the implementation of these measures in new and existing studies. High risk/high payoff projects that lack preliminary data may be more appropriate for FOA RFA-AG-23-023. RFA-AG-23-023 invites Exploratory/Developmental Research Grant (R21) applications. This FOA and RFA-AG-23-023 are companions.

Competitive Salary: F. Hoffmann-La Roche AG: The PositionSenior Backend EngineerLocation: Mississauga or Across CanadaImpact HealthcareRoche Sequencing is not only changing science, but we are ch Ottawa (Region), Ontario (CA)

Notice NOT-RM-22-014 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-DK-22-501 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites a renewal application from UH3 DK118748 supported by RFA-RM-16-019. This FOA will support the continuation and completion of HiLo: A pragmatic trial of higher vs lower serum phosphate targets in patients undergoing hemodialysis. The awardee will continue to enroll and follow hemodialysis patients in the HiLo trial to its completion.

£55000 - £65000 per annum: Hyper Recruitment Solutions (HRS): Senior Data Scientist HRS are recruiting for a Senior Data Scientist to join an innovative Biotech company based in the Cambridge area. Having grown rapidly /... Cambridgeshire

Funding Opportunity RFA-DK-22-509 from the NIH Guide for Grants and Contracts. The Diabetic Foot Consortium (DFC) is the first clinical network for the study of diabetic foot ulcers (DFUs) a common, expensive, and debilitating complication of diabetes that leads to over 100,000 amputations in the United States every year. The DFC was started to address this significant public health problem by building a research infrastructure and validating biomarkers to predict healing or recurrence of DFUs. This Limited Competition Funding Opportunity Announcement (FOA) calls for the renewal of the Clinical Research Units (CRUs) for their support of an expansion of the mission of the DFC with the following goals: 1) develop and validate biomarkers for DFUs;2) accelerate advances in DFU standard care; 3) characterize the role of social determinants of health for DFU healing and recurrence; and 4) build on the DFC infrastructure through ancillary studies and satellite sites. Future research may involve clinical trials and studies on the pathophysiology and prevention of DFUs. All protocol interactions in the DFC will occur at the CRUs. They will recruit participants, collect longitudinal data, images and biosamples and send these data and biosamples to the Data Coordinating Center and Biomarker Analysis Units. They will also collaborate with Satellite sites to accelerate the pace of the DFC studies. As members of the Steering Committee, they will provide leadership in developing protocols and setting priorities for the DFC to best leverage its resources to improve clinical research and care for DFUs.

Notice NOT-HD-22-024 from the NIH Guide for Grants and Contracts